Måndag 17 Februari | 16:10:42 Europe / Stockholm

Bifogade filer

Kalender

Tid*
2026-02-26 08:30 Bokslutskommuniké 2025
2025-11-28 08:30 Kvartalsrapport 2025-Q3
2025-08-28 08:30 Kvartalsrapport 2025-Q2
2025-06-18 N/A Årsstämma
2025-05-22 08:30 Kvartalsrapport 2025-Q1
2025-02-27 08:30 Bokslutskommuniké 2024
2024-11-28 - Kvartalsrapport 2024-Q3
2024-08-27 - Kvartalsrapport 2024-Q2
2024-06-20 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2024-06-19 - Årsstämma
2024-05-23 - Kvartalsrapport 2024-Q1
2024-03-06 - Extra Bolagsstämma 2024
2024-03-05 - Bokslutskommuniké 2023
2023-11-22 - Kvartalsrapport 2023-Q3
2023-08-23 - Kvartalsrapport 2023-Q2
2023-06-19 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2023-06-16 - Årsstämma
2023-05-24 - Kvartalsrapport 2023-Q1
2023-02-23 - Bokslutskommuniké 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2022-05-31 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-02-17 - Bokslutskommuniké 2021
2021-11-11 - Kvartalsrapport 2021-Q3
2021-08-31 - Kvartalsrapport 2021-Q2
2021-05-31 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2021-05-28 - Årsstämma
2021-05-20 - Kvartalsrapport 2021-Q1
2021-02-24 - Bokslutskommuniké 2020
2020-11-12 - Kvartalsrapport 2020-Q3
2020-08-21 - Kvartalsrapport 2020-Q2
2020-05-27 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2020-05-26 - Årsstämma
2020-05-14 - Kvartalsrapport 2020-Q1
2020-02-27 - Bokslutskommuniké 2019
2019-11-14 - Kvartalsrapport 2019-Q3
2019-08-29 - Kvartalsrapport 2019-Q2
2019-05-29 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2019-05-28 - Årsstämma
2019-05-23 - Kvartalsrapport 2019-Q1
2019-02-27 - Bokslutskommuniké 2018
2018-11-15 - Kvartalsrapport 2018-Q3
2018-08-29 - Kvartalsrapport 2018-Q2
2018-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2018-05-31 - Årsstämma
2018-05-15 - Kvartalsrapport 2018-Q1
2018-02-27 - Bokslutskommuniké 2017
2017-11-23 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-06-01 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2017-05-31 - Årsstämma
2017-05-31 - Kvartalsrapport 2017-Q1
2017-05-24 - Kvartalsrapport 2017-Q1
2017-02-23 - Bokslutskommuniké 2016
2016-11-24 - Kvartalsrapport 2016-Q3
2016-08-25 - Kvartalsrapport 2016-Q2
2016-05-24 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2016-05-23 - Årsstämma
2016-05-19 - Kvartalsrapport 2016-Q1
2016-02-25 - Bokslutskommuniké 2015
2015-11-25 - Kvartalsrapport 2015-Q3
2015-08-26 - Kvartalsrapport 2015-Q2
2015-05-29 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2015-05-28 - Årsstämma
2015-05-25 - Kvartalsrapport 2015-Q1
2015-02-26 - Bokslutskommuniké 2014
2014-11-24 - Kvartalsrapport 2014-Q3
2014-08-28 - Kvartalsrapport 2014-Q2
2014-05-22 - Årsstämma
2014-05-22 - Kvartalsrapport 2014-Q1
2014-02-28 - Bokslutskommuniké 2013
2013-11-29 - Kvartalsrapport 2013-Q3
2013-08-26 - Kvartalsrapport 2013-Q2
2013-06-28 - Split AXIC A 4:1
2013-05-30 - Kvartalsrapport 2013-Q1
2013-05-21 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2013-05-20 - Årsstämma
2013-02-28 - Bokslutskommuniké 2012
2012-11-26 - Kvartalsrapport 2012-Q3
2012-08-30 - Kvartalsrapport 2012-Q2
2012-05-28 - Kvartalsrapport 2012-Q1
2012-05-17 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2012-05-16 - Årsstämma
2012-02-29 - Bokslutskommuniké 2011
2011-11-28 - Kvartalsrapport 2011-Q3
2011-08-30 - Kvartalsrapport 2011-Q2
2011-05-30 - Kvartalsrapport 2011-Q1
2011-05-10 - X-dag ordinarie utdelning AXIC A 0.00 SEK
2011-05-09 - Årsstämma
2011-02-25 - Bokslutskommuniké 2010
2010-05-11 - X-dag ordinarie utdelning AXIC A 0.00 SEK

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorMaterial
IndustriPlast, kemikalier & fetter
aXichem är verksamt inom industriell bioteknik. Bolaget utvecklar, patenterar och marknadsför industrikemikalier. Bolaget arbetar framförallt med Fenylcapsaicin, en naturanalog syntetisk capsaicin med tillämpningar inom en mängd olika områden, såsom inom den marina sektorn, bland skadedjursbekämpning i skogs-och jordbruk, samt bland enskilda farmaceutiska arbetsområden. Verksamhet drivs på global nivå, med huvudkontoret i Malmö.
2025-02-04 17:45:00

aXichem AB (publ), developer of innovative natural analogue feed additives and dietary supplement ingredients, announces that the company will increase the number of studies, regarding effect, that form part of the documentation for supplementing aXichem's application for Feed Additive approval in the EU for the company's product phenylcapsaicin as a salmonella-inhibiting additive in chicken feed. The company will conduct one additional effect study and assesses, based on previous positive effect data, that this is the only remaining part for a complete application. The extended studies affect the estimated time of submission to the European Food Safety Authority (EFSA), which the company announced in connection with the presentation of the quarterly report on November 29, 2024.

Torsten Helsing, CEO, comments:

"We have conducted three studies in a clinical environment where chickens were exposed to salmonella at a level that is higher compared to what is seen in an industrial production environment. EFSA's regulations require three studies that demonstrate the product's effect in the use for which the application is intended. Two of the studies show that phenylcapsaicin has a statistically significant salmonella-inhibiting effect, which is very positive. However, study three has given us results that we do not believe meet the criteria for a complete application. Our assessment after analysis is that no changes in the study set up are required, but other factors may have played a role for the study result. We will therefore repeat the study, which will take place as soon as the test facility we have chosen makes it possible. This means that we can submit the additions to EFSA at the earliest when the study has been completed and compiled, and the result contains the data we need for the application. We will notify the market as soon as this happens."

About phenylcapsaicin and aXiphen
The health benefits of chili, with its active ingredient capsaicin have been known for centuries. aXichem's proprietary molecule, phenylcapsaicin, combines the naturally occurring phenyl group with capsaicin, bridged by a triple bond. The result is an innovative natural analogue capsaicin with high purity, where the pungency is greatly reduced.
Production tests and studies have proven the effectiveness of aXiphen® as an ingredient in poultry feed. A production test on on-floor salmonella prevalence, following the inclusion of 15 ppm phenylcapsaicin in a regular starter diet, was carried out in a full-scale commercial broiler production trial under farming conditions. The production test included about 1.6 million broiler chickens. The trial concluded that under the conditions of the test, the inclusion of 15 ppm phenylcapsaicin in broiler chicken feed statistically significantly reduced the number of farms with salmonella-positive floor boot swabs. The European model for production efficiency, EPEF, showed that breeding efficiency increased by 14% compared to traditional feeding.

The information was submitted, through the care of the contact person below, for publication on 4 February 2025, at 17:45 CET.

Company contact:

Torsten Helsing, CEO, aXichem AB
Phone: +46 706 863 355
Email: torsten.helsing@axichem.com

About aXichem

aXichem develops, patents and markets natural analogue industrial chemicals, i.e., synthetically produced substances that have similar and comparable properties to natural substances. The company's first product is phenylcapsaicin, which the company commercializes under two brands, aXiphen® and aXivite®, as an ingredient in animal feed and dietary supplements, respectively. The business is divided into three market areas with different applications for phenylcapsaicin: as an ingredient in feed for poultry, such as chicken and turkey; as an ingredient in food supplements for gut health, weight control and sports and exercise; and as an ingredient in food supplements for the bio-enhancement of curcumin and melatonin. aXichem is listed on the Nasdaq First North Growth Market. Certified advisor for aXichem is Västra Hamnen Corporate Finance AB.
More information is available at
www.axichem.com.